The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML.
 
Jeffrey E. Lancet
Consulting or Advisory Role - Amgen; Asterias Biotherapeutics; Baxalta; Boehringer Ingelheim; Celator; Celgene; Celgene; KaloBios; Karyopharm Therapeutics; Novartis; Shire
Research Funding - Celgene (Inst); Pfizer (Inst)
 
Geoffrey L. Uy
Consulting or Advisory Role - Boehringer Ingelheim; Glycomimetics
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Amphivena Therapeutics; ARIAD; Astellas Pharma; BiolineRx; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Teva (Inst)
 
Laura F. Newell
No Relationships to Disclose
 
Tara L. Lin
No Relationships to Disclose
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Robert K. Stuart
Honoraria - Sunesis Pharmaceuticals
Consulting or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Bayer; Celator; Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Sunesis Pharmaceuticals
 
Stephen Anthony Strickland
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Baxalta; Boehringer Ingelheim; CTI; Daiichi Sankyo; Sunesis Pharmaceuticals
Research Funding - Abbvie; Astellas Pharma; Boehringer Ingelheim; Celator; Cyclacel; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi; Sunesis Pharmaceuticals
 
Donna Hogge
Consulting or Advisory Role - Sanofi
Travel, Accommodations, Expenses - Roche
 
Scott R. Solomon
No Relationships to Disclose
 
Richard M. Stone
Consulting or Advisory Role - Abbvie; Agios; Amgen; Bristol-Myers Squibb; Celator; Celgene; Juno Therapeutics; Karyopharm Therapeutics; Merck; Roche/Genentech; Seagen; Sunesis Pharmaceuticals; Xenetic Biosciences
Research Funding - Agios (Inst); Celator (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Dale L. Bixby
No Relationships to Disclose
 
Jonathan E. Kolitz
No Relationships to Disclose
 
Gary J. Schiller
Research Funding - Celator
 
Matthew Joseph Wieduwilt
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Alexion Pharmaceuticals
Research Funding - Sigma-Tau
 
Daniel H. Ryan
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - Univerty of Rochester
 
Antje Hoering
No Relationships to Disclose
 
Michael Chiarella
Employment - Celator
Stock and Other Ownership Interests - Celator
 
Arthur Chin Louie
Employment - Celator
Leadership - Celator
Stock and Other Ownership Interests - Celator
 
Bruno C. Medeiros
Consulting or Advisory Role - Agios; Amgen; ARIAD; Celgene; Millennium; Novartis; Pfizer; Roche/Genentech
Research Funding - Agios; Celator; Celgene; MEI Pharma; Merck/Schering Plough; Millennium; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Celgene; Millennium